Alex Biese

Oncology nurses provide patients with lung cancer the education and empathy needed to navigate treatment options and adverse event management.

The FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu) for patients with unresectable or metastatic HER2-positive solid tumors who have received prior systemic treatment.

Social support in patients with cervical cancer has the ability to provide patients with answers to some unknowns, and nurses can play a role in helping patients find this type of support.

Patients with metastatic castration-resistant prostate cancer who were previously treated with external beam radiation therapy before radium-223 did not experience an increase in hematological toxicity compared with the overall population.

With pembrolizumab plus chemoradiotherapy now approved by the FDA for patients with advanced cervical cancer, one expert explained the importance of “making sure that patients know what to look for and what to report.”

Treatment with regorafenib in patients with unresectable hepatocellular carcinoma and poor liver function may lead to serious side effects that may result in discontinuation of the treatment.

Kim Noonan, DNP, ANP-BC, AOCN, FAAN, said there are things nurses can do to help manage the risk of thrombotic or cardiovascular events.

Amanda Smith, a registered nurse with Huntsman Cancer Institute, discusses the impact that early satiety can have on patients with myeloproliferative neoplasms and the role nurses play in helping patients manage this symptom.

Kim Noonan, DNP, ANP-BC, AOCN, FAAN, discusses how nurses can help patients with myeloproliferative neoplasms prevent cardiovascular and thrombotic events.

Patients with MPNs should be taught that ‘no symptom is too small to bring to the attention of your nurse.’

According to investigators, digitized cognitive behavioral stress management may help clinicians offer more comprehensive cancer care.